110 related articles for article (PubMed ID: 7397622)
1. Immunotherapeutic effectiveness of BCG inactivated by various modalities.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):480-7. PubMed ID: 7397622
[TBL] [Abstract][Full Text] [Related]
2. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
Kreider JW; Bartlett GL; Purnell DM
Cancer; 1980 Aug; 46(3):500-7. PubMed ID: 7397623
[TBL] [Abstract][Full Text] [Related]
4. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
5. Effect of isonicotinic acid hydrazide on the intratumor injection of BCG.
Sparks FC; Albert NE; Breeding JH
J Natl Cancer Inst; 1977 Feb; 58(2):367-8. PubMed ID: 319244
[TBL] [Abstract][Full Text] [Related]
6. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
7. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
Lee YT
Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
[TBL] [Abstract][Full Text] [Related]
8. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
9. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic trials of murine and guinea-pig solid tumors by oral administration of BCG.
Tokunaga T; Taguchi S; Chino F; Murohashi T
Jpn J Med Sci Biol; 1979 Feb; 32(1):1-18. PubMed ID: 470220
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
Kreider JW; Bartlett GL; Purnell DM; Webb S
Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
14. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery.
Hanna MG; Peters LC
Cancer; 1978 Dec; 42(6):2613-25. PubMed ID: 728864
[TBL] [Abstract][Full Text] [Related]
15. Active specific immunotherapy of established micrometastases with BCG plus tumor cell vaccines: effective treatment of BCG side effects with isoniazid.
Hanna MG; Pollack VA; Peters LC; Hoover HC
Cancer; 1982 Feb; 49(4):659-64. PubMed ID: 7055781
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma.
Zbar B; Hunter J; Rapp HJ; Canti G
Cancer; 1979 Feb; 43(2):484-91. PubMed ID: 421175
[TBL] [Abstract][Full Text] [Related]
17. Single versus double preoperative intralesional BCG in 13762 mammary adenocarcinoma.
Lee YT
J Surg Oncol; 1979; 12(3):243-52. PubMed ID: 502566
[TBL] [Abstract][Full Text] [Related]
18. Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):797-802. PubMed ID: 815563
[TBL] [Abstract][Full Text] [Related]
19. The effect of repeated BCG vaccine administration associated with surgery upon the growth of lung metastases in rats with transplantable Morris 5123 hepatoma.
Nowak HF; Zimnoch L; Jodczyk KJ; Cylwik B; Bernaczyk A; Duda D; Głowinska L; Popko J; Smietańska B
Neoplasma; 1981; 28(2):179-84. PubMed ID: 7254434
[TBL] [Abstract][Full Text] [Related]
20. Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig.
de Boer EC; Steerenberg PA; van der Meijden AP; van Klingeren B; de Jong WH; Debruyne FM; Ruitenberg EJ
Prog Clin Biol Res; 1992; 378():81-93. PubMed ID: 1301589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
